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Abstract
Background: The childhood obesity epidemic is one of the foremost UK health priorities. Childhood obesity tracks
into adult life and places individuals at considerable risk for diabetes, cardiovascular disease, liver disease and other
morbidities. There is widespread need for paediatric lifestyle programmes as change may be easier to accomplish
in childhood than later in life.
Study Design/Method: The study will evaluate the management of adolescent obesity by conducting a Medical
Research Council complex intervention phase III efficacy randomised clinical trial of the Healthy Eating Lifestyle
Programme within primary care. The study tests a community delivered multi-component intervention designed
for adolescents developed from best practice as identified by National Institute for Health and Clinical Excellence.
The hospital based pilot reduced body mass index and improved health-related quality of life.
Subjects will be individually randomised to receiving either the Healthy Eating Lifestyle Programme (12 fortnightly
family sessions) or enhanced standard care. Baseline and follow up assessments will be undertaken blind to
allocation status. A health economic evaluation is also being conducted.
200 obese young people (13-17 years, body mass index > 98th centile for age and sex) will be recruited from
primary care within the greater London area.
The primary hypothesis is that a motivational and solution-focused family-based weight management programme
delivered over 6 months is more efficacious in reducing body mass index in obese adolescents identified in the
community than enhanced standard care.
The primary outcome will be body mass index at the end of the intervention, adjusted for baseline body mass
index, age and sex.
The secondary hypothesis is that the Healthy Eating Lifestyle Programme is more efficacious in improving quality
of life and psychological function and reducing waist circumference and cardiovascular risk factors in obese
adolescents than enhanced standard care assessed at 6 and 12 months post baseline assessment.
Improvement in quality of life predicts on-going lifestyle change and maximises the chances of long-term weight
reduction. We will explore whether improvement in QOL may be intermediate on the pathway between the
intervention and body mass index change.
Trial registration: ISRCTN: ISRCTN99840111
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Background
The obesity epidemic in children and young people is
one of the foremost clinical and public health priorities
in the UK [1]. The UK prevalence of childhood obesity
has > tripled since the 1980s. The UK Government’s
Foresight Report estimates 7-10% of children 5-15 years
are obese using the conservative definitions of the Inter-
national Obesity Task Force [2]. This is predicted to rise
to 14% by 2025 [1]. 1-3% of adolescents 11-15 years
have a BMI ≥ 3.5 standard deviations above the mean,
[2] equivalent to adult morbid obesity (BMI ≥ 40 kg/
m2).
Obesity in childhood is associated with current and
future morbidity [3]. Childhood obesity and cardiovascu-
lar risk factors track strongly through adolescence into
adult life [4,5]. Around 70% of obese children become
obese adults [6] and childhood obesity increases later
cardiovascular and all-cause mortality [7,8]. Other
comorbidities of adult obesity include metabolic syn-
drome, type 2 diabetes, a range of cancers and psycho-
social dysfunction.
Current obesity comorbidity in children is high. Over-
weight and obese children report dramatically lower
quality of life (QOL) than healthy-weight children
[9-11]. Over 70% of obese adolescents have ≥ 1 co-mor-
bidity such as insulin resistance, dyslipidaemia or hyper-
tension; 30% have multiple co-morbidities [12].
Cardiovascular dysfunction related to obesity is identifi-
able in childhood [13,14].
The UK ’s cross-government strategy on obesity,
Healthy Weight, Healthy Lives: A Cross-Government
Strategy for England (January 2008), places a strong
focus on children and outlines multidimensional stra-
tegies for primary and secondary prevention within
and outside the NHS. Each Primary Care Trust (PCT)
has an obesity strategy. As part of this, the National
Child Measurement Programme (NCMP) was estab-
lished in 2005 to weigh and measure children in
Reception (aged 4-5 years) and Year 6 (10-11 years).
The findings are used to inform local planning of ser-
vices for children and gather population-level surveil-
lance data.
Childhood obesity is an identified national priority for
high quality care for the National Health Service in Eng-
land. The recent Child Health Strategy Healthy Lives,
Brighter Futures (2009) identified the reduction of child-
hood obesity as a key part of improving the health and
well-being of children and young people [15].
The NHS has responsibility for treatment of the 7-10%
of children already obese. The UK National Institute of
Health and Clinical Excellence (NICE) guidance in 2006
outlined a Childhood Obesity Pathway (COP) covering
best practice management in primary and secondary
care [16].
The development of an effective childhood obesity
pathway is an important part of improving child health
and reducing NHS burden in the short and long term.
However, while there has been considerable public
health and research attention focused appropriately on
primary and secondary prevention, [1] the management
of those 7-10% of children already obese has been rela-
tively neglected. There is a lack of data on the applica-
tion of the small evidence base for obesity management
[17] which constrains the development of services for
obese children.
NICE outlined optimal therapy as multicomponent
lifestyle modification programmes, however there is a
lack of evidence for effective interventions to tackle obe-
sity. Systematic reviews have found few quality trials,
principally involving small numbers of primary school
aged children, carried out in academic tertiary care cen-
tres with highly specialised staff involving white, middle
class, motivated families [18]. The applicability and gen-
eralisability of these studies is therefore limited, and the
reviews conclude that there is an need for quality trials
of adequate power to be carried out in samples that are
representative of the population at large, where process
evaluation has been addressed and appropriate lifestyle
tools applied.
Whilst lifestyle modification programmes are the most
effective available treatment for childhood obesity, [16]
few include those over 12 years of age and none specifi-
cally target older adolecsents > 15 years. Dramatic cog-
nitive and psychosocial changes during adolescence
make childhood programmes inappropriate for adoles-
cents. Currently adolescents are therefore either
excluded from weight management programmes or
must join inappropriate child or adult programmes.
The HELP programme has been developed to answer
this gap in the childhood obesity pathway. It is a novel
intervention for adolescents 13-17 years based upon
best evidence. The HELP programme was developed
from best practice as identified by NICE [16]. HELP
works as a multi-component intervention that focuses
on enhancing motivation to change and developing self-
efficacy and self-esteem rather than focusing on weight.
Pilot data on BMI change in the HELP programme
from 20 subjects aged 13-17 years showed a mean BMI
reduction 1.7 kg/m2, equivalent to 0.4SD effect size in
the UK population.
Method
Design
HELP is a MRC complex intervention phase III efficacy
randomised clinical trial. Subjects will be individually
randomised to receiving either the HELP intervention or
enhanced standard care for 6 months. Baseline and fol-
low up assessments will be undertaken blind to
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allocation status. An economic evaluation is also being
conducted.
Ethical consideration
Study information packs will be sent to all potentially
eligible young people after the initial screening tele-
phone call. Families will thus have an opportunity to
read the information sheets more than 24 hours before
attending for their baseline study visit. At the baseline
visit, written informed consent will be obtained by one
of the research team from all young people and from
one responsible parent.
There are likely to be few risks relating to participat-
ing in a trial of a pragmatic community-based lifestyle
modification intervention related to obesity. The inter-
vention is based around motivational and solution-
focused psychological approaches. Motivational Inter-
viewing (MI) is a psychological approach developed for
conditions where subjects are reluctant to enter treat-
ment and aims to increase motivation to change beha-
viours. The approach is based on the degree to which
behaviour change is important to an individual, their
confidence in their ability to achieve behaviour change
and the degree to which change is a priority. Solution-
focused therapy (SFT) views the patient rather than
the professionals as the expert in order to identify
“what works” e.g. identifying “what helped” and has
been suggested as a useful technique in weight
management.
The professional working with the young person and
family helps young people explore changing their life-
style to be healthier, and works with existing strengths
and motivation to do this. The control arm consists
only of a single educational session around healthy eat-
ing and healthy activity.
Possible Risks
The potential risks in the study are minimal. There is
the potential for young people to become distressed
during the assessment as a result of the brief physical
examination, blood pressure measurement and comple-
tion of psychological and lifestyle questionnaires. We
anticipate potential psychological issues will be mini-
mal, as the intervention is NOT designed to explore
deep psychological issues or achieve deep psychological
insights, but rather to build on the strengths, resources
and known abilities of young people and their families.
In our pilot work with approximately 20 young people
and families, no young people complained of increased
distress from taking part in the intervention. The pro-
viders will be trained to minimise any possible distress
and deal with any distress that may occur and will
have access to clinicians with extensive clinical
experience.
Burdens
a) Assessment: The study requires a brief physical
examination and venesection at baseline and at week
26. EMLA cream will be offered to reduce pain.
b) Participation in the intervention (i.e. attending for
12 × 45 minute sessions over 6 months) or control
(1 × 40 minute session over 6 months).
The West London Research Ethics Committee 3, part
of the National Research Ethics System (NRES)
approved the study.
The Study intervention
The HELP programme is a solution-focused and motiva-
tional weight management programme. Young people
and families will attend twelve 40-45-minute sessions
over 6 months. A key aspect of the programme is the
use of motivational interviewing and solution-focused
approaches to increase engagement and concordance
with the 4 programme components.
The 4 components are:
a) modifying eating behaviours and encouraging regu-
lar eating patterns
b) decreasing sedentary behaviour and increasing life-
style and programme activity
c) reducing intake of energy dense foods, and increas-
ing healthy nutritional choices
d) addressing emotional eating triggers.
Providers receive training in specific motivational
interviewing techniques and the use of solution focused
questioning. A manual is used to enable delivery in a
standardised manner by all the providers. Self assess-
ment checklists, live observations and audio recordings
of a quasi-random sub-sample of sessions will be used
to record adherence to the programme using a Fidelity
Adherence Scale to assess fidelity to delivery of session
components and adherence to the psychological model.
Structured and semi-structured interviews will be admi-
nistered to providers, young people and their parents to
assess how acceptable the programme was, ease of deliv-
ery, participation and influence on weight, quality of life,
self management, emotional, behavioural and family
functioning. In addition administrative records will be
used to review attendance and service use.
The Control arm
Controls will be offered enhanced standard care, defined
as one prewritten standardised educational session deliv-
ered to young people within three months of recruit-
ment. The Session will be delivered by a practice nurse
at the young person’s general practice. The Session will
be expected to last 40 minutes and will incorporate
standard Department of Health guidance and published
information on obesity. The session will provide
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information addressing eating behaviours, healthy activ-
ity levels and healthy eating patterns. No training in
delivery style will be offered. Where a practice nurse is
not available, a trained nurse practitioner will be pro-
vided by the study team. Fidelity monitoring will be
used on a random subsample of sessions to ensure fide-
lity of information giving and monitor whether deliver-
ing practitioners use motivational or other techniques
which are not part of the control session.
Identification of eligible patients
We will recruit subjects from primary care within the
Greater London area. Data from the Foresight Report
suggest that approximately 7-8% of 13-16 year olds are
obese using a highly conservative definition of obesity
(BMI > IOTF threshold) [1,2]. Greater London contains
415,000 young people 13-17 year old (ONS 2008); con-
servatively 7% are obese, therefore 29,000 are potentially
eligible. We will recruit 200 i.e. 0.6% of this population.
Note that we will use a slightly less conservative defini-
tion of obesity consistent with the NICE guidelines [16]
(BMI > 98th BMI centile on the UK 1990 growth refer-
ence [19]) to define our eligible subjects, so that the
potential pool of subjects is wider than this.
We will identify the young people from the following
sources within the PCTs:
1. Primary care networks. We will advertise and
recruit subjects through:
i. School nurses in all secondary schools in the
region. Nurses will be ask to identify and refer eligi-
ble subjects known to them or presenting to them as
being obese who may benefit from the intervention.
ii. GP practices. These will be contacted through the
PCT networks and through the local Primary Care
Research Network (PCRN). We will:
a. ask GPs to identify and refer eligible subjects
known to them or presenting to them during the
study period as being obese who may benefit
from the intervention.
b. ask practice administrators to identify poten-
tially eligible young people through practice data-
bases, and send them study information packs
asking them to contact the research team if they
are interested in participating.
iii. Other community professionals. Other commu-
nity based professionals such as dieticians will be
asked to identify eligible subjects known to them or
presenting to them during the study period as being
obese who may benefit from the intervention.
2. Advertising. We will place adverts for the study in
community and social media, newsletters and halls.
Adverts will describe the study and will provide contact
details for the research team.
We aim to recruit 200 subjects between Month 4 and
Month 30, i.e. 26 months, being approximately 88 work-
ing weeks i.e. 10 subjects per month.
Initial recruitment will be attractive for young people
as everyone will receive a comprehensive health assess-
ment and evidence-based advice on weight management.
Those young people randomised to the intervention arm
will be able to attend sessions delivered locally and at a
convenient time after school. Recruitment compensation
(a £20 i-tunes or high street store voucher) and travel
costs to attend sessions will be provided for all partici-
pating young people and families.
Determining eligibility for the study/Exclusion criteria
Eligibility (see table 1) for the study is determined in
two stages. Young people and families who respond to
mailed PCT invitations, to advertisement or are referred
by school nurses or primary care professionals will be
contacted by the research team and complete an initial
screening telephone call. Where telephone contact can-
not be made, families and young people will be invited
by letter or email to attend a face to face screening
interview with one of the research team. Young people
identified as eligible will be sent information packs
including information sheets for young people and
families and invited to attend a baseline assessment at
the NIHR Great Ormond St Hospital Clinical Research
Facility (CRF) by the medical research fellow and the
CRF nurses. This appointment is used to formally assess
eligibility through anthropometry, psychological ques-
tionnaires and venepuncture. Formal written consent
will be obtained at this point in the study. If the parent
does not speak adequate English, an interpreter will be
provided to obtain consent if the young person was
under 16 years.
Eligible subjects will then be randomized and a mem-
ber of the study team will be allocated to contact them
to arrange times for them to attend either the interven-
tion of control sessions.
Randomisation
Randomisation will be undertaken independently of the
investigators by the Health Services Research Unit
(HSRU) University of Aberdeen. Randomisation to the
HELP Trial is performed using a secure website. A
minimisation protocol will be used for randomisation
[20]. Allocation to treatment will ensure balance in
respect of one key prognostic variable (sex). The pro-
gram design has been successfully used by HSRU in sev-
eral trials and incorporates the use of a library of stored
procedures to calculate the appropriate treatment based
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on subgroup totals stored in SQL Server 2005 data
tables. Allocation will be 1:1 to Intervention:Control.
The program will generate a 5-digit Study ID. The
first 2 digits identify the recruiting centre (Centre IDs
will be allocated when they join the study) and the last
3 identify the individual patient recruited. This Study ID
number can then be used subsequently to maintain
patient anonymity. At the time of randomisation the
HSRU user will select values for the minimising variable
Gender, then click on the ‘Randomise’ button. The
study number and the allocated treatment will be dis-
played and this data then conveyed to the Trial
Manager.
Assessment
Assessments will be undertaken at the NIHR Great
Ormond St Hospital Clinical Research Facility (CRF) by
the medical research fellow and the CRF nurses using a
standardised protocol who are not involved in delivery
of the intervention and who will be blind to the rando-
misation status of the participants.
The patient’s GP will be informed if the pathology
results are abnormal or concerning.
Outcomes will be measured at Baseline (Week 0),
Week 13, end of intervention (Week 26) and 6 months
post intervention (Week 52) (see table 2).
Outcomes
A. Primary outcome
The primary outcome is the BMI (kg/m2) at the end
of the intervention (Wk 26), adjusted for baseline BMI,
age and sex.
While it is common to use BMI standard deviation
score (SDS) to express change in BMI in children and
adolescents, one of us (Cole) has recently shown that
change in “raw” BMI is the best outcome measure in
obese adolescents, as the skewness in the BMI distribu-
tion means that the same change in kg/m2 will produce
a smaller change in BMI SDS the more obese the sub-
ject is [21].
B. Secondary outcomes
1. Health-related quality of life (HR-QOL) will be
assessed using two measures.
i. The Pediatric Quality of Life Inventory (PedsQL) is
one of the most widely used measures of HR-QOL in
children and adolescents and has proven validity in clin-
ical and population samples [22,23]. It has four core
scales (physical, emotional, social, and school), two
broad domain scores (physical and psychosocial func-
tioning) and a total score. The measure has previously
been used extensively in studies of obese children in
community and clinical samples [24,25].
ii. The Impact of Weight on Quality of Life (IWQOL)-
Kids [26] is a 27-item instrument consisting of four
scales: physical comfort (six items), body esteem (nine
items), social life (six items), and family relations (six
items). It has excellent psychometric properties [26].
Table 1 Study inclusion and exclusion criteria
Inclusion criteria
1 Young people aged 13-17 years living in Greater London
2 Obese, defined as BMI > 98th centile for BMI using the UK 1990 growth reference [19].
Exclusion criteria
1 Participants with significant mental health problems or undergoing mental health treatment.
2 Other chronic illness, known secondary obesity, monogenic obesity syndrome or use of medications known to promote obesity. Young people
with asthma will be included in the study so long as they have not had more than one course of oral steroids in the preceding 3 months (where
course is less than or equal to 5 days), or are on more than the first starting dose of inhaled steroids as per British Thoracic Society Guidelines.
3 Participants with significant learning disability
4 Participants with lack of command of English sufficient to render them unable to participate effectively in the planned intervention. The great
majority of eligible young people from black or minority ethnic groups in this population have good command of English. Given the importance
of standardising the intervention, it will not be possible to use interpreters to enable parents with poor English to participate. To allow as many
young people as possible to participate while maintaining the external validity of the study, we will allow another relative with good English to
participate alongside the young person (if they wish it).
5 Participation in behavioural weight management programmes in the past 12 months. This does not include participation in commercial
programmes such as Weight Watchers.
6 Young people with BMI > = 40 kg/m2. We exclude this group as they are unlikely to benefit from a community based intervention such as HELP.
Table 2 Timing and content of study assessments
Week 0 Week 13 Week 26 Week 52
Anthopometry (BMI, waist) X X X X
Motivation X X X
Quality of life measure X X X
Blood pressure X X X X
Venepuncture X X
Psychological function X X X
Accelerometry X X X
Health economic data EQ5D X X X X
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2. Anthropometric measures (completing using a stan-
dardised protocol):
i. BMI (6 months after end of intervention)
ii. Waist circumference
iii. Non-invasive measurement of fat mass/fat per-
centage by Tanita 418 bioimpedance scales
3. Psychological factors:
i. Eating Attitudes Test, a validated self-report 26
item checklist of issues relating to eating disorder
and body image [27].
ii. Rosenberg Self-Esteem Scale: the most widely
used measure of global self-esteem and has been
determined to be valid and reliable for adolescents
[28].
iii. Psychological health will be measured using the
online version of the Development and Well-being
Assessment (DAWBA) interview [29]. Young people
and families will be asked to complete the DAWBA
confidentially on-line either before or at the assess-
ment. This is a semistructured package of question-
naires and rating techniques designed to generate
ICD-10 and DSM-IV psychiatric diagnoses for 5-17
year olds. It identifies common emotional, beha-
vioural and hyperactivity disorders, and has been
validated in the recent UK national mental health
study of children and adolescents [30].
4. Lifestyle
i. Questions on smoking activities, meal skipping,
sociable eating and frequency of 5 fruit a day intake.
ii. We will use an Actigraph accelerometer [31] 7-
day measurement once in each subject to calibrate
their activity diary.
5. Cardiometabolic risk factors.
i. Fasting insulin and glucose. Insulin resistance will
be estimated using the Homeostatic Model Assess-
ment (HOMA) [32].
ii. Fasting lipids: total cholesterol, HDL-cholesterol,
LDL-cholesterol, triglycerides and total cholesterol/
HDL-C ratio.
iii. Peripheral blood pressure measured accurately
using electronic Dinamap.
6. Health economic data:
A prospective economic evaluation will be conducted
alongside the trial with the aim of estimating the cost-
effectiveness of the HELP intervention versus enhanced
standard care.
Preference-based HR-QOL will be characterized using
the EQ-5D and will be administered to participants at
baseline, month 3, month 6, and month 12. Information
on resource utilisation and on the costs associated with
the HELP and enhanced standard care interventions will
be obtained using observational research methods and
through interviews. The resource utilisation of the ado-
lescents during the trial will be informed using surveys
sent to participants at months 0, 6 and 12. Current UK
unit costs will be applied to each resource item to value
total resource use in each arm of the trial.
Power and sample size
We have powered our study to detect an 0.5 SD effect
size for the primary outcome. This will also detect the
same effect size for secondary outcomes. Our pilot data
identified a likely effect size of 1.7 kg/m2 reduction in
BMI. This is equivalent to 0.6 SD given evidence from
our pilot study and from other interventions [18] that
the SD of change in adolescent BMI is approximately
2.0 kg/m2. Lifestyle modification programmes in obese
children result in improvements in HR-QOL of 0.3-0.5
SD [33,34].
Sample size: 126 subjects is sufficient to detect an
effect size of 0.5 at 80% power and 5% significance. This
sample will be inflated to account for the clustering due
to any persistent therapist effects [35]. Using a therapist
cluster size (C) of 10 subjects and an assuming an ICC
of 0.025, we will require an inflation of our existing
sample size to (126 × (1 + (C-1)*0.025)) = 155. We will
recruit 200 subjects to allow for 20% drop-out.
Statistical analysis
Main analysis of primary outcome: Analyses will be
undertaken by the programme statistician, supervised by
Cole. An intention to treat analysis will be undertaken
for the primary outcome. A linear regression model that
accounts for clustering effects will be fitted. The main
analysis will incorporate correction for missing data.
The model can either be fitted using an EM algorithm
or MCMC approach. This analysis will be performed
adjusted for baseline BMI, age and sex. The biases
caused by missing 3 and 6 months outcome data will be
addressed through multiple imputation by methods that
utilise the number of attempts to achieve response [36]
as well as other sensitivity analyses for informative miss-
ingness [37]. We will undertake a complier average cau-
sal effect (CACE) analysis to identify the difference in
mean outcome amongst compliers. CACE recognizes
the initial randomization and thus overcomes the pro-
blems faced by per-protocol and on-treatment analyses.
Secondary analyses of primary outcome:
a. The main analysis will be repeated without correc-
tion for missing data, e.g. using complete cases analysis
Christie et al. Trials 2011, 12:242
http://www.trialsjournal.com/content/12/1/242
Page 6 of 9
(intention to treat), adjusted for baseline BMI, age and
sex.
b. Complier average causal effect (CACE) analysis to
identify the difference in mean outcome amongst com-
pliers, accounting for missing data, adjusted for baseline
BMI, age and sex.
c. CACE analysis without correction for missing data,
adjusted for baseline BMI, age and sex.
d. Sensitivity analyses for informative missingness.
In this study, compliance for the intervention arm is
defined as fulfilling the following criteria: 1) attendance
to session one, 2) attendance to at least one session in
each of the four modules of the intervention, and 3)
attendance to a minimum of eight of the twelve sessions
in total. Participants in the intervention arm failing to
fulfil one or more of these criteria are classified as non-
compliers.
Main analysis of secondary outcomes:
In addition to secondary outcomes listed above, BMI
at 6 months after end of intervention (Week 52) is
included as a secondary outcome. Similarly to the pri-
mary outcome analyses, an intention to treat analysis
will be applied. A linear or logistic regression model
that accounts for clustering effects will be fitted for con-
tinuous and binary outcomes, respectively. For ordinal
outcomes, such as LIKERT scale outcomes, an ordinal
logistic regression model will be fitted. The main analy-
sis will incorporate correction for missing data.
Secondary analyses of secondary outcomes:
a. The main analysis will be repeated without correc-
tion for missing data, e.g. using complete cases analysis
(intention to treat), adjusted for baseline BMI, age and
sex.
b. CACE analysis to identify the difference in mean
outcome amongst compliers, accounting for missing
data, adjusted for baseline BMI, age and sex.
c. CACE analysis without correction for missing data,
adjusted for baseline BMI, age and sex.
Software: Depending on the choice of implementation,
standard software for generalised linear models, e.g.
STATA (to implement EM algorithm) or WinBUGS (to
implement MCMC) will be used for the main analyses.
Reporting of the statistical analyses will follow CON-
SORT guidelines.
Economic evaluation
The economic evaluation will be conducted from the
public services (NHS, education, personal and social ser-
vices) perspective in the primary analysis, and from the
societal prospective in a sensitivity analysis.
The primary effectiveness outcome will be quality
adjusted life years (QALYs) measured over a time hori-
zon of 1 year based on EQ-5D scores collected during
the trial; secondary analysis will examine the IWQoL to
inform non preference-based cost-effectiveness analyses.
The following cost components will be included in the
analysis: weight-related inpatient and outpatient hospi-
tal, primary care and child and adolescent mental health
services contacts; any other NHS treatments, or treat-
ment paid for by the PCT, received to support weight
loss; the cost of additional support provided at school;
benefit receipt, family and social fund support, and the
receipt of direct payments from social services or regis-
tered charities; and the impact of child care on parents’
ability to work. Cost-effectiveness will be measured
based on the incremental cost per QALY gained of the
intervention versus the control. We shall use non-para-
metric bootstrap estimation to derive 95% confidence
intervals for mean cost and effect differences between
the trial groups and to calculate 95% confidence inter-
vals around the incremental cost effectiveness ratios.
A series of univariate, multi-way and probabilistic sen-
sitivity analyses will be undertaken to explore the impli-
cations of uncertainty on the incremental cost-
effectiveness ratios and to consider the broader issue of
the generalisability of the study results. The sensitivity
analyses will include extending the baseline cost-effec-
tiveness model to a life-time time horizon using Markov
modelling. We will construct cost-effectiveness accept-
ability curves constructed using the net benefits
approach.
Discussion
Since receiving funding and ethical approval the inter-
vention team have developed a comprehensive 5 day
training programme for the providers. This has included
training in good clinical practice and the background to
obesity causes and consequences. Risk management and
child protection training has also been included. Follow-
ing training in specific motivational interviewing techni-
ques and the use of solution focused questioning the
providers have been trained to deliver the 12 modules
through a combination of description, small group work
and role play. A manual is used to enable delivery in a
standardised manner by all the providers. After comple-
tion of the training all providers have observed a trained
clinician delivering the intervention and have been
observed delivering their first sessions by the team clini-
cal psychologist. Self assessment checklists, live observa-
tions and audio recordings are used to record adherence
to the programme using a Fidelity Adherence Scale to
assess fidelity to delivery of session components and
adherence to the psychological model. Providers also
receive regular clinical supervision.
The prewritten standardised educational session has
been delivered to Control subjects by practice nurses.
We have piloted and refined a questionnaire to monitor
fidelity of information giving and whether practice
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nurses have experience or training in motivational or
other techniques.
The Chief Investigators (DC and RV) ensure that
there are monthly trial management meetings with the
research and intervention teams and we have been
developing working relationships with GP practices and
community resources in order to deliver the interven-
tion in convenient locations for families.
As the project has been developing we have developed
transparent operating procedures to ensure consistency
of response to drop outs or families failing to attend
intervention sessions.
Both Trial Steering and Data Monitoring and Ethics
Committees have been appointed and the first meetings
with the team have been completed.
Trial Status
The HELP study is a 51 month study.
The Set-up phase took place in Months 1-6. The pro-
viders were recruited and trained to deliver the interven-
tion and control arms in M 6-9. Recruitment of young
people commenced in M9 and will continue till M33.
Baseline assessments commenced in M12 and will con-
tinue for 2 years till M36. Subjects were randomised in
M12, and delivery of intervention and control arms will
run from M12 to M 42. Final data collection will occur
M18 to 42. Database completion, analysis and writing
up will occupy M45-51.
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